EEF1A2 and neoplasm: Another potential avenue for solid tumors is to target tumor-restricted post-translational modifications, such as overexpression of truncated O-glycans such as Tn (GalNAca1-O-Ser/Thr) and sialyl-Tn (STn) (NeuAca2–6-GalNAca1-O-Ser/Thr) (Steentoft et al., 2018).